Oracle Named A Leader By IDC Marketscape For Life Science R&D

The life sciences industry is recognizing the importance of adopting new technologies in pharmacovigilance.

International Data Corporation (IDC), the premier global provider of market intelligence, advisory services, and events for the information technology, telecommunications, and consumer technology markets, has released a new report on pharmacovigilance solution vendors. “The industry is rapidly investing in developing intelligent, scalable, and compliant safety platforms that can handle the exploding volumes of adverse events and ensure timely reporting to health authorities,” notes the IDC MarketScape in an overview of the market.

“As the number of AEs continues to grow significantly year over year, manual case processing no longer remains an option..”

Oracle has been named a Leader in the report.

Global assessment: Oracle unsurpassed

The “IDC MarketScape: Worldwide Life Science R&D Pharmacovigilance Solutions 2022 Vendor Assessment” (doc #US48061622 , December 2022) report evaluated 11 pharmacovigilance vendors from around the world.

The assessment looked at key attributes that life science companies are looking for in their preferred PV solution providers.

“It’s gratifying to see this independent assessment from a leading research firm,” says Henry McNamara, senior vice president and general manager for Oracle Health Sciences.

“This appraisal not only echoes what we’re hearing from our customers and partners, but it aligns with our strategic mission – to provide a flexible, open technology platform that allows life sciences organizations to automate safety operations and detect risks earlier.”

Detect early, automate processes, and increase compliance

Powered by AI, the Safety One platform provides compliant pharmacovigilance from clinical trials through post-marketing surveillance, allowing safety teams to manage cases and signals faster, more accurately, and more efficiently.

Integrating the market-leading Argus, Empirica, Oracle Analytics, and Safety One Intake solutions on a single SaaS cloud platform, Safety One gives life science organizations confidence that their IT landscape is future-proof and scalable to their needs as they grow.

Safety One enables pharmacovigilance professionals to detect product risks and operational risks early, reduce the cost of end-to-end multivigilance via AI and automations, and increase compliance with regulations.

“With integrated solutions encompassing case intake and management, signal detection and management, and reporting and analytics, we’re intent on being a trusted partner for life sciences firms as they accelerate their digital transformations,” says McNamara.

Advancing and expanding

As the industry leader, Oracle is committed to pursuing new advances to stay abreast of scientific breakthroughs, regulatory change, technological advances, and the market forces that affect pharmacovigilance and multivigilance.

“We continue to aggressively expand and strengthen capabilities across the medicinal product safety spectrum, from advancing machine learning and artificial intelligence, to incorporating real-world data and unlocking sophisticated new solutions through our acquisition of Cerner,” says McNamara. “Our customers and their patients depend on it.”

Learn more about Oracle Pharmacovigilance.

Michael McCann, Global Vice President Sales, Alliances and Channels

Michael McCann has over 30 years of experience in enterprise technology across life sciences domains including drug discovery, clinical development, regulatory and commercial. He has been the global sales leader for Oracle's Health Sciences group since its October 2020. Prior to that he led the Americas Health Sciences sales organization since the business unit’s inception in 2008.

As the global sales leader, Michael is responsible for the growth of clinical development and pharmacovigilance solutions relied upon by biotech, pharma, medical device, and CRO customers. Prior to Oracle he was part of the life sciences group at Siebel Systems, VP of Sales at Active Strategy, VP of Sales at EMAX Solutions, Sales VP at Computer Associates, and software engineer at Unisys Corporation.

Michael McCann holds a Bachelor of Arts degree in Computer Science and Finance from LaSalle University and an MBA in International Business from the LeBow College of Business at Drexel University.